semaglutide weight loss graph results week by week: timeline from first dose to full results Weight Change With Semaglutide
Description
Many insurers still refuse to cover brand-name GLP-1 products for weight loss
By helping beta cells survive and thrive, GLP-1 contributes to an effective insulin response in the future
Based on Lilly's confirmed plan to submit regulatory applications in 2026, and typical FDA review timelines of 6-12 months, the earliest realistic availability date is 2027
Wegovy and Zepbound are both FDA-approved for chronic weight management and are taken as weekly injections
